However, homozygous loss of RBL1 or RBL2 was rarely observed in metastatic castration-resistant prostate cancer samples from various data sets, and no positive association was found between ACSL4 expression and inactivation of RBL1 or RBL2 (Supplemental Figure 4, I and J). This evidence concerns the gene RBL2 and prostate cancer.